Read More Pharma Industry News Silexion Therapeutics’ SIL-204 shows promise in transforming pancreatic cancer treatment Silexion Therapeutics, a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies, has released compelling preclinical data for its… byPallavi MadhirajuJanuary 16, 2025